Complete response in a patient with advanced melanoma following anti-PD-1 therapy is associated with a high frequency of melanoma-infiltrating CXCR3+ resident memory CD8+ T cells and multiple chemokine pathways

Complete response in a patient with advanced melanoma following anti-PD-1 therapy is associated with a high frequency of melanoma-infiltrating CXCR3⁺ resident memory CD8⁺ T cells and multiple chemokine pathways

Br J Dermatol. 2021 Sep;185(3):663-666. doi: 10.1111/bjd.20405. Epub 2021 Jun 14.

L Dousset^{1

2}, C Martins², C Jacquemin², S Amico¹, T Schatton³, K Boniface², J Seneschal^{1

2}

¹ Department of Dermatology and Paediatric Dermatology, National Reference Center for Rare Skin Disorders, Hôpital Saint-André, Bordeaux, France.
² INSERM U1035, BMGIC, Immuno-Dermatology, University of Bordeaux, Bordeaux, France.
³ Harvard Skin Disease Research Center, Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, 02115, USA.

No abstract available